COOPER WARREN D sold 0.1% of their position (40.00 shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $40.40 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/16/2022ACC: 0001062993-22-015038
Director
Since Jun 2019
+57.73K
Net shares
Net buyer
$40.40
Total sold
1
Open market trades
0B · 1S
3
Total transactions
57.77K acquired · 40.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+23.11K
Price / share
—
Trade value
—
% of position
462.2%
6/14/2022
5K→28.11K
Common Stock
Direct
Shares
−40.00
Price / share
$1.01
Trade value
$40.40
% of position
0.1%
6/14/2022
28.11K→28.07K
Total
Net shares
+23.07K
Net value
-$40.40
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/14/2022 | A · Award | +23.11K | — | — | 462.2% | 5K | 28.11K |
| Common Stock Direct | 6/14/2022 | S · Sale | −40.00 | $1.01 | $40.40 | 0.1% | 28.11K | 28.07K |
| Total | +23.07K | -$40.40 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
34.66K shares
Shares
+34.66K
Strike price
1.01
Held after
34.66K
Exercisable
—
6/14/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock34.66K shares | 6/14/2022 | A · Award | +34.66K | 1.01 | — | 34.66K |